Klaus Bister

  1. Linke KH, Taubert R, Bister K, Bornatsch W, Liem BJ. Contributions to the chemistry of hydrazine and its derivatives, XXIII. Reactions of barium hydrazide. Z. Naturforsch. 26b, 296‑298 (1971). CC-BY-ND

  2. Stoffel W, Assmann G, Bister K. Metabolism of sphingosine bases, XVII. Stereospecificities in the introduction of the 4t‑double bond into sphinganine yielding 4t‑sphingenine (sphingosine). Hoppe‑Seyler's Z. Physiol. Chem. 352, 1531‑1544 (1971). PMID: 5140816 - DOI: 10.1515/bchm2.1971.352.2.1531

  3. Stoffel W, Bister K. Stereospecificities in the metabolic reactions of the four isomeric sphinganines (dihydrosphingosines) in rat liver. Hoppe‑Seyler's Z. Physiol. Chem. 354, 169‑181 (1973). PMID: 4372143 - DOI: 10.1515/bchm2.1973.354.1.169

  4. Stoffel W, Bister K. Studies on the desaturation of sphinganine. Ceramide and sphingomyelin metabolism in the rat and in BHK21 cells in tissue culture. Hoppe‑Seyler's Z. Physiol. Chem. 355, 911‑923 (1974). PMID: 4435766 - DOI: 10.1515/bchm2.1974.355.2.911

  5. Stoffel W, Bister K. 13C nuclear magnetic resonance studies on the lipid organization in enveloped virions (vesicular stomatitis virus). Biochemistry 14, 2841‑2847 (1975). PMID: 167809 - DOI: 10.1021/bi00684a008

  6. Stoffel W, Bister K, Schreiber C, Tunggal B. 13C‑NMR studies of the membrane structure of enveloped virions (vesicular stomatitis virus). Hoppe‑Seyler's Z. Physiol. Chem. 357, 905‑915 (1976). PMID: 186376 - DOI: 10.1515/bchm2.1976.357.2.905

  7. Bister K, Varmus HE, Stavnezer E, Hunter E, Vogt PK. Biological and biochemical studies on the inactivation of avian oncoviruses by ultraviolet irradiation. Virology 77, 689‑704 (1977). PMID: 193258 - DOI: 10.1016/0042-6822(77)90492-5

  8. Bister K, Hayman MJ, Vogt PK. Defectiveness of avian myelocytomatosis virus MC29: Isolation of long‑term nonproducer cultures and analysis of virus‑specific polypeptide synthesis. Virology 82, 431‑448 (1977). PMID: 199997 - DOI: 10.1016/0042-6822(77)90017-4

  9. Duesberg PH, Bister K, Vogt PK. The RNA of avian acute leukemia virus MC29. Proc. Natl. Acad. Sci. USA 74, 4320‑4324 (1977). PMID: 200913

  10. Bister K, Vogt PK, Hayman MJ. MC29, a highly defective avian acute leukemia virus. In Avian RNA Tumor Viruses (Barlati S, de Giuli‑Morghen C, eds), pp. 57‑66. Piccin Editore, Padova (1978).

  11. Duesberg PH, Vogt PK, Bister K, Troxler D, Scolnick EM. Oncogenic (onc) genes of sarcoma, leukemia and carcinoma viruses. In AvianRNA Tumor Viruses (Barlati S, de Giuli‑Morghen C, eds), pp. 95‑111. Piccin Editore, Padova (1978).

  12. Hayman MJ, Bister K, Vogt PK, Royer‑Pokora B, Graf T. Viral polyprotein synthesis in cells infected with avian sarcoma‑leukemia viruses. In Avian RNA Tumor Viruses (Barlati S, de Giuli‑Morghen C, eds), pp. 214‑226. Piccin Editore, Padova (1978).

  13. Bister K, Vogt PK. Genetic analysis of the defectiveness in strain MC29 avian leukosis virus. Virology 88, 213‑221 (1978). PMID: 211711 - DOI: 10.1016/0042-6822(78)90278-7

  14. Duesberg P, Mellon P, Pawson T, Martin GS, Bister K, Vogt P. Defining transforming (onc) genes and gene products of avian acute leukemia and carcinoma viruses. In Persistent Viruses, UCLA Symposia on Molecular and Cellular Biology, Vol. XI (Stevens JG, Todaro GJ, Fox CF, eds), pp. 245‑266. Academic Press, New York (1978).

  15. Mellon P, Pawson A, Bister K, Martin GS, Duesberg PH. Specific RNA sequences and gene products of MC29 avian acute leukemia virus. Proc. Natl. Acad. Sci. USA 75, 5874‑5878 (1978). PMID: 215999

  16. Vogt PK, Bister K, Hu SSF, Hayman MJ. On the nature of defectiveness in avian oncoviruses MC29 and MH2. In Oncogenic Viruses and Host Cell Genes (Ikawa Y, Odaka T, eds), pp. 83‑93. Academic Press, New York (1979).

  17. Duesberg PH, Vogt PK, Bister K, Troxler D, Scolnick EM. Oncogenic (onc) genes of sarcoma, leukemia and carcinoma viruses. In Oncogenic Viruses and HostCell Genes (Ikawa Y, Odaka T, eds), pp. 95‑115. Academic Press, New York (1979).

  18. Duesberg P, Mellon P, Pawson A, Bister K, Vogt PK. Anatomy of the RNA and gene products of MC29 and MH2, two defective avian tumor viruses causing acute leukemia and carcinoma: Evidence for a new class of transforming genes. Haematol. Blood Transfus. 23, 241-260 (1979). PMID: 232456

  19. Yamamoto N, Bister K, zur Hausen H. Retinoic acid inhibition of Epstein‑Barr virus induction. Nature 278, 553‑554 (1979). PMID: 219367 - DOI: 10.1038/278553a0

  20. Bister K, Yamamoto N, zur Hausen H. Differential inducibility of Epstein‑Barr virus in cloned, non‑producer Raji cells. Int. J. Cancer 23, 818‑825 (1979). PMID: 89100 - DOI: 10.1002/ijc.2910230613

  21. Bister K, Löliger HC, Duesberg PH. Oligoribonucleotide map and protein of CMII: Detection of conserved and nonconserved genetic elements in avian acute leukemia viruses CMII, MC29 and MH2. J. Virol. 32, 208‑219 (1979). PMID: 232172

  22. Bister K, Duesberg PH. Structure and specific sequences of avian erythroblastosis virus RNA: Evidence for multiple classes of transforming genes among avian tumor viruses. Proc. Natl. Acad. Sci. USA 76, 5023‑5027 (1979). PMID: 228273

  23. Duesberg PH, Bister K, Moscovici C. Avian acute leukemia virus MC29: Conserved and variable RNA sequences and recombination with helper virus. Virology 99, 121‑134 (1979). PMID: 227156 - DOI: 10.1016/0042-6822(79)90043-6

  24. Bister K, Duesberg PH. Genetic structure of avian acute leukemia viruses. Cold Spring Harbor Symp. Quant. Biol. 44, 801‑822 (1980). PMID: 6253214 - DOI: 10.1101/SQB.1980.044.01.086

  25. Bister K, Duesberg PH. Avian erythroblastosis virus RNA: Identification and comparison to nondefective helper and defective acute leukemia viral RNAs. In In vivo and in vitro Erythropoiesis: The Friend System (Rossi GB, ed), pp. 515‑526. Elsevier/North‑Holland, Amsterdam (1980).

  26. Sheiness D, Bister K, Moscovici C, Fanshier L, Gonda T, Bishop JM. Avian retroviruses that cause carcinoma and leukemia: Identification of nucleotide sequences associated with pathogenicity. J. Virol. 33, 962‑968 (1980). PMID: 6245277

  27. Lee WH, Bister K, Pawson A, Robins T, Moscovici C, Duesberg PH. Fujinami sarcoma virus: An avian RNA tumor virus with a unique transforming gene. Proc. Natl. Acad. Sci. USA 77, 2018‑2022 (1980). PMID: 6246518

  28. Bister K, Lee WH, Robins T, Duesberg PH. Fujinami sarcoma virus and sarcomagenic, avian acute leukemia viruses have similar genetic structures. In Animal Virus Genetics, UCLA Symposia on Molecular and Cellular Biology, Vol. XVIII (Fields BN, Jaenisch R, Fox CF, eds), pp. 527‑539. Academic Press, New York (1980).

  29. Duesberg PH, Bister K, Moscovici C. Genetic structure of avian myeloblastosis virus, released from transformed myeloblasts as a defective virus particle. Proc. Natl. Acad. Sci. USA 77, 5120‑5124 (1980). PMID: 6159639

  30. Bister K, Lee WH, Duesberg PH. Phosphorylation of the nonstructural proteins encoded by three avian acute leukemia viruses and by Fujinami sarcoma virus. J. Virol. 36, 617‑621 (1980). PMID: 6253683

  31. Bister K, Ramsay G, Hayman MJ, Duesberg PH. OK10, an avian acute leukemia virus of the MC29 subgroup with a unique genetic structure. Proc. Natl. Acad. Sci. USA 77, 7142‑7146 (1980). PMID: 6261241

  32. Duesberg PH, Bister K. Transforming genes of retroviruses: Definition, specificity and relation to cellular DNA. In Feline Leukemia Virus (Hardy WD, Essex M, McClelland AJ, eds), pp. 273‑292. Elsevier/North‑Holland, New York (1980).

  33. Duesberg PH, Bister K. Transforming genes of retroviruses: Definition, specificity and relation to cellular DNA. Haematol. Blood Transfus. 26, 383-396 (1981). PMID: 6274750

  34. Bister K, Duesberg PH. Two different designs of transforming genes in retroviruses. In Antiviral Chemotherapy: Design of Inhibitors of Viral Functions (Gauri KK, ed), pp. 1‑10. Academic Press, New York (1981).

  35. Duesberg PH, Bister K. Transforming genes of retroviruses: Definition, specificity and relation to cellular DNA. In Cancer: Achievements, Challenges, and Prospects for the 1980s (Burchenal JH, Oettgen HF, eds), pp. 111‑136. Grune & Stratton, New York (1981).

  36. Lee WH, Bister K, Moscovici C, Duesberg PH. Temperature‑sensitive mutants of Fujinami sarcoma virus: Tumorigenicity and reversible phosphorylation of the transforming p140 protein. J. Virol. 38, 1064‑1076 (1981). PMID: 6264151

  37. Robins T, Bister K, Garon C, Papas T, Duesberg PH. Structural relationship between a normal chicken DNA locus and the transforming gene of the avian acute leukemia virus MC29. J. Virol. 41, 635‑642 (1982). PMID: 6281474

  38. Duesberg P, Robins T, Lee WH, Bister K, Garon C, Papas T. On the relationship between the transforming onc genes of avian Rous sarcoma and MC29 viruses and homologous loci of the chicken cell. In Expression of Differentiated Functions in Cancer Cells (Revoltella RP, Pontieri GM, Basilico C, Rovera G, Gallo RC, Subak‑Sharpe JH, eds), pp. 471‑484. Raven Press, New York (1982).

  39. Duesberg P, Robins T, Lee WH, Garon C, Papas T, Bister K. Transforming genes of avian retroviruses and their relation to cellular prototypes. In Advances in Comparative Leukemia Research 1981 (Yohn DS, Blakeslee JR, eds), pp. 279‑296. Elsevier/North‑Holland, New York (1982).

  40. Bister K, Ramsay G, Hayman MJ. Deletions within the transformation‑specific RNA sequences of acute leukemia virus MC29 give rise to partially transformation‑defective mutants. J. Virol. 41, 754‑766 (1982). PMID: 6284968

  41. Bister K, Nunn M, Moscovici C, Perbal B, Baluda MA, Duesberg PH. Acute leukemia virus E26 and avian myeloblastosis virus have related transformation‑specific RNA sequences but different genetic structures, gene products and oncogenic properties. Proc. Natl. Acad. Sci. USA 79, 3677‑3681 (1982). PMID: 6285358

  42. Bister K, Duesberg PH. Genetic structure and transforming genes of avian retroviruses. In Advances in Viral Oncology, Vol.1 (Klein G, ed), pp. 3-42. Raven Press, New York (1982).

  43. Ramsay G, Hayman MJ, Bister K. Phosphorylation of specific sites in the gag‑myc polyproteins encoded by MC29‑type viruses correlates with their transforming ability. EMBO J. 1, 1111‑1116 (1982). PMID: 6985357

  44. Duesberg P, Robins T, Lee WH, Garon C, Papas T, Bister K. Transforming genes of avian retroviruses and their relation to cellular prototypes. In Biochemical and Biological Markers of Neoplastic Transformation (Chandra P, ed), pp. 409‑431. Plenum Press, New York (1983).

  45. Hayman MJ, Enrietto PJ, Ramsay GM, Bister K, Graf T, Payne LN. Studies on the molecular basis of the oncogenic potential of the avian myelocytomatosis virus MC29. In Tumor Viruses and Differentiation, UCLA Symposia on Molecular and Cellular Biology, New Series Vol. 5 (Scolnick EM, Levine AJ, eds), pp. 263‑277. Alan R. Liss, New York (1983).

  46. Bister K, Nunn M, Duesberg P, Moscovici C. Genetic structure and gene products of erythroblastosis virus E26 and myeloblastosis virus AMV. In Tumor Viruses and Differentiation, UCLA Symposia on Molecular and Cellular Biology, New Series Vol. 5 (Scolnick EM, Levine AJ, eds), pp. 289‑297. Alan R. Liss, New York (1983).

  47. Bister K, Enrietto P, Graf T, Hayman M. The transforming gene of avian acute leukemia virus MC29. Haematol. Blood Transfus. 28, 173-177 (1983). PMID: 6305786

  48. Bister K, Jansen HW, Graf T, Enrietto P, Hayman MJ. Genome structure of HBI, a variant of acute leukemia virus MC29 with unique oncogenic properties. J. Virol. 46, 337‑346 (1983). PMID: 6302305

  49. Jansen HW, Patschinsky T, Bister K. Avian oncovirus MH2: Molecular cloning of proviral DNA and structural analysis of viral RNA and protein. J. Virol. 48, 61‑73 (1983). PMID: 6310159

  50. Jansen HW, Rueckert B, Lurz R, Bister K. Two unrelated cell‑derived sequences in the genome of avian leukemia and carcinoma inducing retrovirus MH2. EMBO J. 2, 1969‑1975 (1983). PMID: 6315409

  51. Bister K. Molecular biology of avian acute leukaemia viruses. In Mechanisms of Viral Leukaemogenesis, Leukaemia and Lymphoma Research, Vol. 1 (Goldman JM, Jarrett O, eds), pp. 38‑63. Churchill Livingstone, Edinburgh (1984).

  52. Jansen HW, Lurz R, Bister K, Bonner TI, Mark GE, Rapp UR. Homologous cell‑derived oncogenes in avian carcinoma virus MH2 and murine sarcoma virus 3611. Nature 307, 281‑284 (1984). PMID: 6319999 - DOI: 10.1038/307281a0

  53. Sutrave P, Bonner TI, Rapp UR, Jansen HW, Patschinsky T, Bister K. Nucleotide sequence of avian retroviral oncogene v‑mil: Homologue of murine retroviral oncogene v‑raf. Nature 309, 85‑88 (1984). PMID: 6325930 -  DOI: 10.1038/309085a0

  54. Bister K, Lurz R, Jansen HW, Sutrave P, Bonner TI, Rapp UR. The mil/raf oncogene. In Genes and Cancer, UCLA Symposia on Molecular and Cellular Biology, New Series Vol. 17 (Bishop JM, Rowley JD, Greaves M, eds), pp. 315‑328. Alan R. Liss, New York (1984).

  55. Patschinsky T, Walter G, Bister K. Immunological analysis of v‑myc gene products using antibodies against a myc‑specific synthetic peptide. Virology 136, 348‑358 (1984). PMID: 6331679 - DOI: 10.1016/0042-6822(84)90171-5

  56. Jansen HW, Trachmann C, Bister K. Structural relationship between the chicken protooncogene c‑mil and the retroviral oncogene v‑mil. Virology 137, 217‑224 (1984). PMID: 6089417 - DOI: 10.1016/0042-6822(84)90028-X

  57. Sutrave P, Jansen HW, Bister K, Rapp UR. 3'‑Terminal region of avian carcinoma virus MH2 shares sequence elements with avian sarcoma viruses Y73 and SR‑A. J. Virol. 52, 703‑705 (1984). PMID: 6092695

  58. Vogt PK, Bister K, Burny AL, Croce CM, Haseltine WA, Hayman MJ, Hayward WS, Klein G, Moelling K, Neth RD, Pragnell IB, Rowley JD. Genes and viruses able to transform hematopoietic cells. In Leukemia (Weissman IL, ed), pp. 275‑292. Springer, Berlin - Heidelberg (1985).

  59. Jansen HW, Patschinsky T, Walther N, Lurz R, Bister K. Molecular and biological properties of MH2D12, a spontaneous mil deletion mutant of avian oncovirus MH2. Virology 142, 248‑262 (1985). PMID: 4060574 - DOI: 10.1016/0042-6822(85)90333-2

  60. Walther N, Lurz R, Patschinsky T, Jansen HW, Bister K. Molecular cloning of proviral DNA and structural analysis of the transduced myc oncogene of avian oncovirus CMII. J. Virol. 54, 576‑585 (1985). PMID: 2985820

  61. Rapp UR, Bonner TI, Moelling K, Jansen HW, Bister K, Ihle J. Genes and gene products involved in growth regulation of tumor cells. Recent Results Cancer Res. 99, 221‑236 (1985). PMID: 4070776

  62. Jansen HW, Trachmann C, Patschinsky T, Bister K. The mil/raf and myc oncogenes: Molecular cloning and in vitro mutagenesis. Haematol. Blood Transfus. 29, 280-283 (1985). PMID: 2993117

  63. Jansen HW, Bister K. Nucleotide sequence analysis of the chicken gene c‑mil, the progenitor of the retroviral oncogene v‑mil. Virology 143, 359‑367 (1985). PMID: 2998016 - DOI: 10.1016/0042-6822(85)90376-9

  64. Rapp UR, Cleveland JL, Fredrickson TN, Holmes KL, Morse III HC, Jansen HW, Patschinsky T, Bister K. Rapid induction of hemopoietic neoplasms in newborn mice by a raf(mil)/myc recombinant murine retrovirus. J. Virol. 55, 23‑33 (1985). PMID: 4009794

  65. Bister K, Jansen HW, Patschinsky T. Virale und zelluläre Onkogene. In Aktuelle Onkologie, Vol. 24 (Nagel GA, Sauer R, Schreiber HW, Schuff‑Werner P, Pfitzenmaier K, eds), pp. 3‑9. Zuckschwerdt, München (1985).

  66. Bister K, Jansen HW. Oncogenes in retroviruses and cells: Biochemistry and molecular genetics. Adv. Cancer Res. 47, 99‑188 (1986). PMID: 3022566 - DOI: 10.1016/S0065-230X(08)60199-2

  67. Cleveland JL, Jansen HW, Bister K, Fredrickson TN, Morse III HC, Ihle JN, Rapp UR. Interaction between raf and myc oncogenes in transformation in vivo and in vitro. J. Cell. Biochem. 30, 195‑218 (1986). PMID: 3084503 - DOI: 10.1002/jcb.240300303

  68. Patschinsky T, Schroeer B, Bister K. Protein product of protooncogene c‑mil. Mol. Cell. Biol. 6, 739‑744 (1986). PMID: 3537695

  69. Bister K. Structure and function of myc and mil oncogenes. In Cell Cycle and Oncogenes, 37th Colloquium Mosbach 1986 (Tanner W, Gallwitz D, eds), pp. 75‑81. Springer, Berlin - Heidelberg (1986). DOI: 10.1007/978-3-642-71686-7_9

  70. Graf T, v Weizsaecker F, Grieser S, Coll J, Stehelin D, Patschinsky T, Bister K, Bechade C, Calothy G, Leutz A. v‑mil induces autocrine growth and enhanced tumorigenicity in v‑myc transformed avian macrophages. Cell 45, 357‑364 (1986). PMID: 3698101

  71. Patschinsky T, Jansen HW, Blöcker H, Frank R, Bister K. Structure and transforming function of transduced mutant alleles of the chicken c‑myc gene. J. Virol. 59, 341‑353 (1986). PMID: 3016301

  72. Walther N, Jansen HW, Trachmann C, Bister K. Nucleotide sequence of the CMII v‑myc allele. Virology 154, 219‑223 (1986). PMID: 3019003 - DOI: 10.1016/0042-6822(86)90444-7

  73. Bister K, Trachmann C, Jansen HW, Schroeer B, Patschinsky T. Structure of mutant and wild‑type MC29 v‑myc alleles and biochemical properties of their protein products. Oncogene 1, 97‑109 (1987). PMID: 3438084

  74. Bister K. Multiple cell-derived sequences in single retroviral genomes. In Advances in Viral Oncology, Vol.6 (Klein G, ed), pp. 45-70. Raven Press, New York (1987).

  75. Koenen M, Sippel AE, Trachmann C, Bister K. Primary structure of the chicken c‑mil protein: Identification of domains shared with or absent from the retroviral v‑mil protein. Oncogene 2, 179‑185 (1988). PMID: 3285296

  76. Patschinsky T, Bister K. Structural analysis of normal and transforming mil(raf) proteins: Effect of 5' truncation on phosphorylation in vivo and in vitro. Oncogene 3, 357‑364 (1988). PMID: 3274084

  77. Kerkhoff E, Bister K. Myc protein structure: Localization of DNA‑binding and protein dimerization domains. Oncogene 6, 93‑102 (1991). PMID: 1992448

  78. Kerkhoff E, Bister K, Klempnauer KH. Sequence‑specific DNA binding by Myc proteins. Proc. Natl. Acad. Sci. USA 88, 4323‑4327 (1991). PMID: 1827916

  79. Bister K, Kerkhoff E. Structure and function of the myc oncogene. In Advances in Molecular Genetics, Vol. 3 (Issinger OG, Henke J, Kömpf J, Driesel AJ, eds), pp. 65‑75. Hüthig, Heidelberg (1991).

  80. Weiskirchen R, Siemeister G, Hartl M, Bister K. Sequence and expression of a glyceraldehyde‑3‑phosphate dehydrogenase‑encoding gene from quail embryo fibroblasts. Gene 128, 269‑272 (1993). PMID: 8514192

  81. Weiskirchen R, Bister K. Suppression in transformed avian fibroblasts of a gene (crp) encoding a cysteine‑rich protein containing LIM domains. Oncogene 8, 2317‑2324 (1993). PMID: 8361751

  82. Bister K, Kerkhoff E, Siemeister G, Weiskirchen R. Biochemistry of recombinant v‑Myc proteins and differential gene expression in v‑myc‑transformed cells. In Virus Strategies (Doerfler W, Böhm P, eds), pp. 409‑420. VCH Publishers, Weinheim - New York (1993).

  83. Dong Q, Blatter EE, Ebright YW, Bister K, Ebright RH. Identification of amino acid‑base contacts in the Myc‑DNA complex by site‑specific bromouracil mediated photocrosslinking. EMBO J. 13, 200‑204 (1994). PMID: 8306962

  84. Hartl M, Vogt PK, Bister K. A quail long‑term cell culture transformed by a chimeric jun oncogene. Virology 207, 321‑326 (1995). PMID: 7871748

  85. Weiskirchen R, Pino J, Macalma T, Bister K, Beckerle MC. The cysteine‑rich protein (CRP) family of highly related LIM‑domain proteins. J. Biol. Chem. 270, 28946‑28954 (1995). PMID: 7499425

  86. Hartl M, Bister K. Specific activation in jun‑transformed avian fibroblasts of a gene (bkj) related to the avian β‑keratin gene family. Proc. Natl. Acad. Sci. USA 92, 11731‑11735 (1995). PMID: 8524838 

  87. Mink S, Mutschler B, Weiskirchen R, Bister K, Klempnauer KH. A novel function for Myc: Inhibition of C/EBP‑dependent gene activation. Proc. Natl. Acad. Sci. USA 93, 6635‑6640 (1996). PMID: 8692870 

  88. Oberst C, Weiskirchen R, Hartl M, Bister K. Suppression in transformed avian fibroblasts of a gene (CO6) encoding a membrane protein related to mammalian potassium channel regulatory subunits. Oncogene 14, 1109‑1116 (1997). PMID: 9070660

  89. Konrat R, Weiskirchen R, Kräutler B, Bister K. Solution structure of the carboxyl‑terminal LIM domain from quail cysteine‑rich protein CRP2. J. Biol. Chem. 272, 12001‑12007 (1997). PMID: 9115265

  90. Weiskirchen R, Erdel M, Utermann G, Bister K. Cloning, structural analysis and chromosomal localization of the human CSRP2 gene encoding the LIM domain protein CRP2. Genomics 44, 83‑93 (1997). PMID: 9286703

  91. Konrat R, Weiskirchen R, Bister K, Kräutler B. Bispheric coordinative structuring in a zinc finger protein: NMR analysis of a point mutant of the carboxy‑terminal LIM domain of quail cysteine‑ and glycine‑rich protein CRP2. J. Am. Chem. Soc. 120, 7127-7128 (1998). DOI: 10.1021/ja973599k

  92. Kontaxis G, Konrat R, Kräutler B, Weiskirchen R, Bister K. Structure and intramodular dynamics of the amino‑terminal LIM domain of quail cysteine and glycine‑rich protein CRP2. Biochemistry 37, 7127-7134 (1998). PMID: 9585524

  93. Konrat R, Kräutler B, Weiskirchen R, Bister K. Structure of cysteine- and glycine-rich protein CRP2: Backbone dynamics reveal motional freedom and independent spatial orientation of the LIM domains. J. Biol. Chem. 273, 23233-23240 (1998). PMID: 9722554

  94. Hartl M, Bister K. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation. Oncogene 17, 2901-2913 (1998). PMID: 9879996

  95. Oberst C, Hartl M, Weiskirchen R, Bister K. Conditional cell transformation by doxycycline-controlled expression of the MC29 v-myc allele. Virology 253, 193-207 (1999). PMID: 9918878 

  96. Kloiber K, Weiskirchen R, Kräutler B, Bister K, Konrat R. Mutational analysis and NMR spectroscopy of quail cysteine and glycine-rich protein CRP2 reveal an intrinsic segmental flexibility of LIM domains. J. Mol. Biol. 292, 893-908 (1999). PMID: 10525413

  97. Bader AG, Hartl M, Bister K. Conditional cell transformation by doxycycline-controlled expression of the ASV17 v-jun allele. Virology 270, 98-110 (2000). PMID: 10772983

  98. Kontaxis G, Matt T, Schüler W, Kräutler B, Bister K, Konrat R. Sequence-specific resonance assignments of Q83, a lipocalin highly expressed in v-myc-transformed avian fibroblasts. J. Biomol. NMR 17, 177-178 (2000). PMID: 10921782 - DOI: 10.1023/A:1008386018430

  99. Fieber W, Schneider ML, Matt T, Kräutler B, Konrat R, Bister K. Structure, function, and dynamics of the dimerization and DNA binding domain of oncogenic transcription factor v-Myc. J. Mol. Biol. 307, 1395-1410 (2001). PMID: 11292350

  100. Schüler W, Kloiber K, Matt T, Bister K, Konrat R. Application of cross-correlated NMR spin relaxation to the zinc-finger protein CRP2(LIM2): Evidence for collective motions in LIM domains. Biochemistry 40, 9596-9604 (2001). PMID: 11583159

  101. Bader AG, Schneider ML, Bister K, Hartl M. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1). Oncogene 20, 7524-7535 (2001). PMID: 11709724

  102. Hartl M, Reiter F, Bader AG, Castellazzi M, Bister K. JAC, a direct target of oncogenic transcription factor Jun, is involved in cell transformation and tumorigenesis. Proc. Natl. Acad. Sci. USA 98, 13601-13606 (2001). PMID: 11698665

  103. Hartl M, Bader AG, Bister K. Molecular targets of the oncogenic transcription factor Jun. Curr. Cancer Drug Targets 3, 41-55 (2003). PMID: 12570660

  104. Hartl M, Matt T, Schüler W, Siemeister G, Kontaxis G, Kloiber K, Konrat R, Bister K. Cell transformation by the v-myc oncogene abrogates c-Myc/Max-mediated suppression of a C/EBPβ-dependent lipocalin gene. J. Mol. Biol. 333, 33-46 (2003). PMID: 14516741

  105. Kontaxis G, Bister K, Konrat R. LIM domain proteins. In Handbook of Metalloproteins, Vol. 3 (Messerschmidt A, Bode W, Cygler M, eds), pp. 378-389. Wiley, New York (2004). DOI: 10.1002/0470028637.met022

  106. Baminger B, Ludwiczek ML, Hoffmann B, Kontaxis G, Bister K, Konrat R. Backbone assignment of the dimerization and DNA-binding domain of the oncogenic transcription factor v-Myc in complex with its authentic binding partner Max. J. Biomol. NMR 30, 361-362 (2004). PMID: 15756464 - DOI: 10.1007/s10858-005-1058-z

  107. Hartl M, Karagiannidis AI, Bister K. Cooperative cell transformation by Myc/Mil(Raf) involves induction of AP-1 and activation of genes implicated in cell motility and metastasis. Oncogene 25, 4043-4055 (2006). PMID: 16491116

  108. Reiter F, Hartl M, Karagiannidis AI, Bister K. WS5, a direct target of oncogenic transcription factor Myc, is related to human melanoma glycoprotein genes and has oncogenic potential.Oncogene 26, 1769-1779 (2007). PMID: 16964280

  109. Schedlbauer A, Ozdowy P, Kontaxis G, Hartl M, Bister K, Konrat R. Backbone assignment of osteopontin, a cytokine and cell attachment protein implicated in tumorigenesis. Biomol. NMR Assign. 2, 29-31 (2008). PMID: 19636917

  110. Karagiannidis AI, Bader AG, Hartl M, Bister K. TOJ3, a v-jun target with intrinsic oncogenic potential, is directly regulated by Jun via a novel AP-1 binding motif. Virology 378, 371-376 (2008). PMID: 18603277

  111. Hartl M, Nist A, Khan MI, Valovka T, Bister K. Inhibition of Myc-induced cell transformation by brain acid-soluble protein 1 (BASP1). Proc. Natl. Acad. Sci. USA 106, 5604-5609 (2009). PMID: 19297618

  112. Hartl M, Mitterstiller AM, Valovka T, Breuker K, Hobmayer B, Bister K. Stem cell-specific activation of an ancestral myc protooncogene with conserved basic functions in the early metazoan Hydra. Proc. Natl. Acad. Sci. USA 107, 4051-4056 (2010). PMID: 20142507

  113. Coudevylle N, Geist L, Hötzinger M, Hartl M, Kontaxis G, Bister K, Konrat R. The v‑myc-induced Q83 lipocalin is a siderocalin. J. Biol. Chem. 285, 41646-41652 (2010). PMID: 20826777 

  114. Aigner M, Hartl M, Fauster K, Steger J, Bister K, Micura R. Chemical synthesis of site-specifically 2'-azido-modified RNA and potential applications for bioconjugation and RNA interference. ChemBioChem 12, 47-51 (2011). PMID: 21171007 

  115. Ganisl B, Valovka T, Hartl M, Taucher M, Bister K, Breuker K. Electron detachment dissociation for top-down mass spectrometry of acidic proteins. Chem. Eur. J. 17, 4460-4469 (2011). PMID: 21433149 

  116. Platzer G, Schedlbauer A, Chemelli A, Ozdowy P, Coudevylle N, Auer R, Kontaxis G, Hartl M, Miles AJ, Wallace BA, Glatter O, Bister K, Konrat R. The metastasis-associated extracellular matrix protein osteopontin forms transient structure in ligand interaction sites. Biochemistry 50, 6113-6124 (2011). PMID: 21609000

  117. Coudevylle N, Hoetzinger M, Geist L, Kontaxis G, Hartl M, Bister K, Konrat R. Lipocalin Q83 reveals a dual ligand binding mode with potential implications for the functions of siderocalins. Biochemistry 50, 9192-9199 (2011). PMID: 21951132

  118. Fauster K, Hartl M, Santner T, Aigner M, Kreutz C, Bister K, Ennifar E, Micura R. 2'‑Azido RNA, a versatile tool for chemical biology: Synthesis, X-ray structure, siRNA applications, and click labeling. ACS Chem. Biol. 7, 581-589 (2012). PMID: 22273279

  119. Bister K. MC29 avian myelocytomatosis virus. In Brenner's Encyclopedia of Genetics, 2nd edition, Vol. 4 (Maloy S, Hughes K, eds), pp. 330-332. Academic Press, San Diego (2013). DOI: 10.1016/B978-0-12-374984-0.00913-X

  120. Hartl M, Bister K. Oncogenes. In Brenner's Encyclopedia of Genetics, 2nd edition, Vol. 5  (Maloy S, Hughes K, eds), pp. 164-166. Academic Press, San Diego (2013). DOI: 10.1016/B978-0-12-374984-0.01089-5

  121. Kizilsavas G, Saxena S, Zerko S, Kozminski W, Bister K, Konrat R. 1H, 13C, and 15N backbone and side chain resonance assignments of the C-terminal DNA binding and dimerization domain of v-Myc. Biomol. NMR Assign. 7, 321-324 (2013). PMID: 23179058

  122. Hartl M, Bister K. Analyzing Myc in cell transformation and evolution. Methods Mol. Biol. 1012, 21-49 (2013). PMID: 24006056

  123. Valovka T, Schönfeld M, Raffeiner P, Breuker K, Dunzendorfer-Matt T, Hartl M, Bister K. Transcriptional control of DNA replication licensing by Myc. Sci. Rep. 3:3444 (2013). PMID: 24309437

  124. Bachmann VA, Bister K, Stefan E. Interplay of PKA and Rac: Fine-tuning of Rac localization and signaling. Small GTPases 4, 247–251 (2013). PMID: 24322054

  125. Santner T, Hartl M, Bister K, Micura R. Efficient access to 3'-terminal azide-modified RNA for inverse click-labeling patterns. Bioconjugate Chem. 25, 188-195 (2014). PMID: 24358989

  126. Hartl M, Glasauer S, Valovka T, Breuker K, Hobmayer B, Bister K. Hydra myc2, a unique pre-bilaterian member of the myc gene family, is activated in cell proliferation and gametogenesis. Biol. Open 3, 397-407 (2014).  PMID: 24771621

  127. Hart JR, Garner AL, Yu J, Ito Y, Sun M, Ueno L, Rhee J-K, Baksh MM, Stefan E, Hartl M, Bister K, Vogt PK, Janda KD. Inhibitor of MYC identified in a Kröhnke pyridine library. Proc. Natl. Acad. Sci. USA 111, 12556-12561 (2014). PMID: 25114221

  128. Raffeiner P, Röck R, Schraffl A, Hartl M, Hart JR, Janda KD, Vogt PK, Stefan E, Bister K. In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential. Oncotarget 5, 8869-8878 (2014). PMID: 25326649

  129. Röck R, Bachmann V, Bhang HC, Malleshaiah M, Raffeiner P, Mayrhofer JE, Tschaikner PM, Bister K, Aanstad P, Pomper MG, Michnick SW, Stefan E. In vivo recordings of binary PKA network interactions upon activation of endogenous GPCRs. Sci. Rep. 5:11133 (2015). PMID: 26099953

  130. Jud L, Kosutic M, Schwarz V, Hartl M, Kreutz C, Bister K, Micura R. Expanding the scope of 2'-SCF3 modified RNA. Chem. Eur. J. 21, 10400-10407 (2015). PMID: 26074479

  131. Stefan E, Hart JR, Bister K. Stopping MYC in its tracks. Aging 7, 463-464 (2015). PMID: 26187009

  132. Bister K. Discovery of oncogenes: The advent of molecular cancer research. Proc. Natl. Acad. Sci. USA 112, 15259-15260 (2015). PMID: 26644573

  133. Raffeiner P, Schraffl A, Schwarz T, Röck R, Ledolter K, Hartl M, Konrat R, Stefan E, Bister K. Calcium-dependent binding of Myc to calmodulin. Oncotarget 8, 3327-3343 (2017). PMID: 27926480

  134. Stefan E, Bister K. MYC and RAF: Key effectors in cellular signaling and major drivers in human cancer. Curr. Top. Microbiol. Immunol. 407, 117-151 (2017). PMID: 28466200

  135. Hunter E, Bister K (eds). Viruses, Genes, and Cancer - Current Topics in Microbiology and Immunology, Vol. 407. Springer International Publishing (2017). DOI: 10.1007/978-3-319-61804-3

  136. Stefan E, Troppmair J, Bister K. Targeting the architecture of deregulated protein complexes in cancer. Adv. Protein Chem. Struct. Biol., in press (2017). DOI: 10.1016/bs.apcsb.2017.07.001

  137. Gufler S, Artes B, Bielen H, Krainer I, Eder MK, Falschlunger J, Bollmann A,  Ostermann T, Valovka T, Hartl M, Bister K, Technau U, Hobmayer B. β-Catenin acts in a position-independent regeneration response in the simple eumetazoan HydraDev. Biol., in press (2017).